Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2545-2555
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2545
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2545
Figure 1 Flow diagram shows the patient selection criteria.
BCLC: Barcelona Clinic Liver Cancer; HCC: Hepatocellular carcinoma; PS: Performance status; TACE: Trans arterial chemoembolization.
Figure 2 Kaplan-Meier estimated survival curves stratified according to Barcelona clinic liver cancer stages (A) or to Barcelona clinic liver cancer nomogram stratified in 5 classes (0-5), (5-10), (10-15), (15-19), (≥ 20) (B).
Figure 3 Overall survival Histograms according to HKLC staging system, CLIP score and NIACE score in our hepatocellular carcinoma cohort.
Figure 4 Survival time in months according to hepatocellular carcinoma nomogram.
Hsu et al[27] in our hepatocellular carcinoma cohort.
- Citation: Adhoute X, Pénaranda G, Raoul JL, Edeline J, Blanc JF, Pol B, Campanile M, Perrier H, Bayle O, Monnet O, Beaurain P, Muller C, Castellani P, Le Treut YP, Bronowicki JP, Bourlière M. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort. World J Gastroenterol 2017; 23(14): 2545-2555
- URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2545.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2545